Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1418-1423

  Barcelo A ^a,b   Pierola J ^a,b   De La Pena M ^a,b   Esquinas, C ^c   Fuster, A ^a   Sanchez de la Torre, M ^b,c   Carrera, M ^a,b   Alonso Fernandez, A ^a,b   Ladaria, A ^a   Bosch, M ^a   Barbe F ^b,c  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Free fatty acids; Metabolic syndrome; Sleep apnoea

Indexed keywords

8 ISOPROSTANE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SLEEP APNEA, OBSTRUCTIVE; SMOKING; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 79958007214     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00050410     Document Type: Article

References (33)

1. Douglas NJ, Polo O. Pathogenesis of sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 653-655.
2. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239. (Pubitemid 34461732)
3. Bonsignore MR, Eckel J. Metabolic aspects of obstructive sleep apnoea syndrome. Eur Respir Rev 2009; 18: 113-124.
4. Levy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-260.
5. Lam JC, Ip MS. An update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulm Med 2007; 13: 484-489. (Pubitemid 47494196)
6. Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008; 134: 686-692.
7. Arnardottir ES, Mackiewicz M, Gislason T, et al. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009; 32: 447-470.
8. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008; 37: 635.
9. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000; 11: 351-356.
10. Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 2007; 24: 934-945. (Pubitemid 47304378)
11. Pilz S, Marz W. Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med 2008; 46: 429-434. (Pubitemid 351820374)
12. Frayn KN, Fielding BA, Karpe F. Adipose tissue fatty acid metabolism and cardiovascular disease. Curr Opin Lipidol 2005; 16: 409-415. (Pubitemid 41017624)
13. Tripathy D, Mohanty P, Dhindsa S, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003; 52: 2882-2887. (Pubitemid 37466856)
14. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-741. (Pubitemid 38647933)
15. Drager LF, Queiroz EL, Lopes HF, et al. Obstructive sleep apnea is highly prevalent and correlates with impaired glycemic control in consecutive patients with the metabolic syndrome. J Cardiometab Syndr 2009; 4: 89-95.
16. Muraki I, Tanigawa T, Yamagishi K, et al. Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS Study. J Atheroscler Thromb 2010; 17: 369-377.
17. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414. (Pubitemid 46135879)
18. Opie LH. Metabolic syndrome. Circulation 2007; 115: e32-e35. (Pubitemid 46148516)
19. Bonsignore MR, Zito A. Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk. Arch Physiol Biochem 2008; 114: 255-260.
20. Drager LF, Bortolotto LA, Maki-Nunes C, et al. The incremental role of obstructive sleep apnoea onmarkers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010; 208: 490-495.
21. Liu Z, Liu J, Jahn LA, et al. Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab 2009; 94: 3543-3549.
22. Sarafidis PA, Bakris GL. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance? J Hum Hypertens 2007; 21: 12-19.
23. Koutsari C, Jensen MD. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 2006; 47: 1643-1650.
24. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007; 10: 142-148. (Pubitemid 46220305)
25. Alam I, Lewis K, Stephens JW, et al. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev 2007; 8: 119-127. (Pubitemid 46239440)
26. Jun J, Polotsky VY. Sleep disordered breathing andmetabolic effects: evidence from animal models. Sleep Med Clin 2007; 2: 263-277.
27. Trayhurn P. Adipocyte biology. Obes Rev 2007; 8: Suppl. 1, 41-44.
28. Hosogai N, Fukuhara A, OshimaK, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911. (Pubitemid 46525054)
29. Lam DC, Xu A, Lam KS, et al. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur Respir J 2009; 33: 346-351.
30. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005; 97: 698-706. (Pubitemid 41416339)
31. Borgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 2006; 27: 121-127. (Pubitemid 43092675)
32. Campbell J, Martucci AD, Green GR. Plasma albumin as an acceptor of free fatty acids. Biochem J 1964; 93: 183-189.
33. Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 2010; 9: 9.